Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.15%735M | -31.90%1.8B | -69.45%212M | 4.22%791M | -83.97%100M | 22.85%699M | 18.07%2.65B | 64.07%694M | -12.46%759M | 25.30%624M |
| Net income from continuing operations | -3.16%582M | 91.90%1.09B | -49.71%87M | 978.26%248M | 4.76%154M | 167.11%601M | -45.65%568M | -43.65%173M | -80.51%23M | 234.09%147M |
| Operating gains losses | 70.00%-78M | -52.94%-26M | 10.34%192M | 168.49%50M | 94.97%-8M | -734.15%-260M | 97.75%-17M | 448.00%174M | -46.00%-73M | -1,545.45%-159M |
| Depreciation and amortization | 4.98%337M | 11.42%1.3B | 16.72%335M | 8.36%324M | 8.53%318M | 12.24%321M | 9.91%1.17B | 7.89%287M | 9.93%299M | 10.98%293M |
| Asset impairment expenditure | ---- | -64.95%75M | --0 | --0 | ---- | ---- | --214M | --4M | --210M | ---- |
| Deferred tax | -13.87%118M | 137.17%71M | 76.59%-48M | 94.12%-1M | -241.67%-17M | 621.05%137M | -296.91%-191M | -612.50%-205M | 52.78%-17M | 119.67%12M |
| Other non cashItems | -178.79%-184M | -88.79%51M | -27.59%21M | -2.17%45M | -84.06%51M | -210.00%-66M | -48.88%455M | 172.50%29M | -86.71%46M | 27.49%320M |
| Change In working capital | -17.65%-40M | -267.48%-757M | -261.64%-375M | -53.87%125M | -4,400.00%-473M | 45.16%-34M | 575.79%452M | 332.00%232M | 24.88%271M | 200.00%11M |
| -Change in receivables | 367.50%107M | -356.49%-703M | -53.07%-473M | -70.71%29M | -3,750.00%-219M | -180.00%-40M | -123.58%-154M | -296.15%-309M | 3,200.00%99M | -95.68%6M |
| -Change in inventory | -8.00%23M | -265.79%-63M | 450.00%21M | -200.00%-31M | -85.71%-78M | -54.55%25M | 222.58%38M | -115.00%-6M | 875.00%31M | 58.00%-42M |
| -Change in payables and accrued expense | -108.61%-315M | -107.46%-40M | -78.50%129M | 15.22%53M | -150.71%-71M | 39.60%-151M | 199.63%536M | 19,900.00%600M | -66.42%46M | 976.92%140M |
| -Change in other current liabilities | 9.85%145M | 53.13%49M | 1.89%-52M | -22.11%74M | -12.90%-105M | 59.04%132M | 117.88%32M | 18.46%-53M | 17.28%95M | -47.62%-93M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.15%735M | -31.90%1.8B | -69.45%212M | 4.22%791M | -83.97%100M | 22.85%699M | 18.07%2.65B | 64.07%694M | -12.46%759M | 25.30%624M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -23.16%-872M | -56.99%-3.48B | -3.77%-964M | 3.20%-846M | -610.05%-964M | -17.22%-708M | 23.96%-2.22B | -6.54%-929M | -24.50%-874M | 126.88%189M |
| Net PPE purchase and sale | -21.41%-879M | -12.09%-3.53B | -4.09%-966M | 3.42%-846M | -33.51%-996M | -20.47%-724M | -7.29%-3.15B | -6.18%-928M | -23.03%-876M | -4.48%-746M |
| Net business purchase and sale | ---- | --0 | --0 | --0 | ---- | ---- | --927M | --0 | --0 | ---- |
| Net other investing changes | -56.25%7M | 733.33%50M | 300.00%2M | --0 | 300.00%32M | 633.33%16M | -70.00%6M | -150.00%-1M | -80.00%2M | -27.27%8M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -23.16%-872M | -56.99%-3.48B | -3.77%-964M | 3.20%-846M | -610.05%-964M | -17.22%-708M | 23.96%-2.22B | -6.54%-929M | -24.50%-874M | 126.88%189M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,695.12%2.21B | 325.06%1.84B | 402.79%900M | 6,300.00%64M | 206.20%754M | 142.71%123M | -187.11%-818M | -76.84%179M | 100.43%1M | -387.45%-710M |
| Net issuance payments of debt | 738.85%2.18B | 596.76%2.45B | 324.11%1.07B | 3,228.57%219M | 257.69%902M | 254.76%260M | -145.70%-494M | -51.06%253M | 92.63%-7M | -255.01%-572M |
| Net common stock issuance | 890.00%198M | -83.45%47M | -91.67%7M | -93.33%10M | -47.37%10M | -35.48%20M | -33.02%284M | -79.05%84M | 3,650.00%150M | 58.33%19M |
| Cash dividends paid | -8.28%-170M | -6.55%-651M | -8.86%-172M | -9.33%-164M | -3.95%-158M | -3.97%-157M | -10.29%-611M | -6.76%-158M | -7.91%-150M | -14.29%-152M |
| Net other financing activities | ---1M | -400.00%-9M | ---8M | ---- | ---- | ---- | 125.00%3M | --0 | 300.00%8M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,695.12%2.21B | 325.06%1.84B | 402.79%900M | 6,300.00%64M | 206.20%754M | 142.71%123M | -187.11%-818M | -76.84%179M | 100.43%1M | -387.45%-710M |
| Net cash flow | ||||||||||
| Beginning cash position | 67.87%371M | -62.41%221M | -13.26%229M | -42.78%218M | 21.38%335M | -62.41%221M | 77.11%588M | -3.30%264M | 13.73%381M | -8.61%276M |
| Current changes in cash | 1,716.67%2.07B | 141.28%161M | 364.29%148M | 107.89%9M | -206.80%-110M | 135.29%114M | -248.29%-390M | -117.28%-56M | -65.22%-114M | 145.24%103M |
| Effect of exchange rate changes | --37M | -147.83%-11M | -146.15%-6M | 166.67%2M | -450.00%-7M | --0 | 428.57%23M | 244.44%13M | -142.86%-3M | 122.22%2M |
| End cash Position | 640.00%2.48B | 67.87%371M | 67.87%371M | -13.26%229M | -42.78%218M | 21.38%335M | -62.41%221M | -62.41%221M | -3.30%264M | 13.73%381M |
| Free cash from | -476.00%-144M | -242.57%-1.73B | -222.22%-754M | 52.99%-55M | -634.43%-896M | 21.88%-25M | 27.44%-505M | 48.12%-234M | -175.48%-117M | 43.52%-122M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.